James W. Green - 13 Jun 2024 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Chief Executive Officer, Director
Signature
/s/ David Sirois, by power of attorney
Issuer symbol
HBIO
Transactions as of
13 Jun 2024
Net transactions value
+$29,100
Form type
4
Filing time
14 Jun 2024, 16:02:29 UTC
Previous filing
07 Jun 2024
Next filing
31 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Purchase $29,100 +10,000 +0.32% $2.91 3,111,091 13 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (a) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 RSUs that will vest on December 29, 2024, (c) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (d) 699,772 RSUs with performance based vesting conditions and (e) 1,908,749 shares of common stock beneficially owned by the Reporting Person.